Palisade Bio, Inc.
PALI
$1.67
-$0.17-9.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.18% | 16.43% | 2.57% | -17.38% | -7.79% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -25.00% | -25.00% | -50.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.33% | -66.38% | -4.53% | 11.53% | 32.70% |
| Change in Net Operating Assets | -60.12% | 104.01% | -46.61% | 247.75% | -7.05% |
| Cash from Operations | 19.70% | 20.05% | -5.18% | -9.52% | -7.40% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.43% | 15.33% | 24.51% | -8.95% | 33.27% |
| Issuance of Common Stock | 27.85% | -46.28% | -13.40% | -10.19% | -54.81% |
| Repurchase of Common Stock | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 12.49% | 54.02% | -47.81% | -48.95% | 1.39% |
| Cash from Financing | 37.55% | -47.02% | -16.76% | -14.34% | -59.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.32% | -17.54% | -100.20% | -5,428.57% | -648.00% |